Received Jul 28, 2026
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| COVID19 | COVID19 (COVID19 (PFIZER-BIONTECH)) | PFIZER\BIONTECH | 1 | — | — |
Lymphedema worse; Lymphedema worse; This is a spontaneous report received from a Consumer or other non HCP, Program ID. A patient (age and gender not provided) received BNT162b2 omicron (lp.8.1) (COMIRNATY (2025-2026 FORMULA)), as dose 1, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: LYMPHOEDEMA (non-serious), CONDITION AGGRAVATED (non-serious), outcome "unknown" and all described as "Lymphedema worse". The information on the batch/lot number for BNT162b2 omicron (lp.8.1) will be requested and submitted if and when received.